Latin Times on MSN1 天
California Woman in Pink Hoodie Set Fire to Target Christmas Decorations, Fled on Purple Bike
A woman set fire to a Christmas decoration display inside a California Target then fled the scene on a purple bike.
pharmaphorum1 天
Roche rings Bicycle bell again, grabbing another cancer target
Bicycle's immuno-oncology pipeline is headed by BT7480, a tumour-targeted immune cell agonist (TICA) that binds to Nectin-4 on cancer cells and stimulates CD137 on immune cells, driving an immune ...
Fintel on MSN7 天
Stephens & Co. Initiates Coverage of Bicycle Therapeutics plc - Depositary Receipt () (BCYC ...
Fintel reports that on November 8, 2024, Stephens & Co. initiated coverage of Bicycle Therapeutics plc - Depositary Receipt ( ...
Investing16 天
Leerink raises Bicycle Therapeutics target to $32 on pipeline progress
On Thursday, Leerink Partners demonstrated confidence in Bicycle Therapeutics (NASDAQ:BCYC) as they raised the company's price target to $32.00 from the previous $30.00, while maintaining an ...
Investing23 天
Bicycle Therapeutics retains stock target and Buy rating on promising data
On Thursday, H.C. Wainwright maintained a Buy rating and a $55.00 price target on shares of Bicycle Therapeutics (NASDAQ: NASDAQ:BCYC), following the release of promising imaging data for the ...
Bicycle Therapeutics: Looking Again At An Intriguing Developmental Concern
Bicycle Therapeutics is a biopharma company targeting unmet medical needs. Discover why BCYC stock benefits from strong ...
Investing23 天
Bicycle Therapeutics retains stock target and Buy rating on promising data
On Thursday, H.C. Wainwright maintained a Buy rating and a $55.00 price target on shares of Bicycle Therapeutics (NASDAQ: NASDAQ:BCYC), following the release of promising imaging data for the ...
Is Bicycle Therapeutics plc (BCYC) Top Performing European Stock Heading into 2025?
Headquartered in Cambridge, the United Kingdom, Bicycle Therapeutics plc (NASDAQ:BCYC) is a clinical-stage biopharmaceutical ...